BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Biocurate - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Biocurate
X-ORIGINAL-URL:https://www.biocurate.com
X-WR-CALDESC:Events for Biocurate
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20190406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20191005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20200404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20201003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20210403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20211002T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20220402T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20221001T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20230401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20230930T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20180331T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20181006T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20190406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20191005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20200404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20201003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20210403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20211002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Shanghai
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:CST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240913
DTEND;VALUE=DATE:20240914
DTSTAMP:20240611T065343Z
CREATED:20240611T065343Z
LAST-MODIFIED:20240611T065343Z
UID:3393-1726185600-1726271999@www.biocurate.com
SUMMARY:ImmuMon 2024
DESCRIPTION:ImmuMon (Immunology at Monash) 2024 is the fifth Immunology Symposium at Monash to be held on September 13\, 2024. ImmuMon promotes scientific exchange and links early-mid career postdoctoral scientists and PhD students working in the broader field of immunology across major Monash campuses: Monash Biomedicine Discovery Institute\, Alfred Research Alliance\, School of Clinical Sciences and Hudson Institute of Medical Research.\n\n\n\n\n\nThe symposium is a great opportunity to share your research and provides an opportunity for networking and collaboration\, as well as highlight the diversity of knowledge and skills possessed by researchers across Monash University. \n\nBioCurate is the Gold Sponsor of ImmuMon 2024\n\nMore information and registration details can be found here.
URL:https://www.biocurate.com/event/immumon-2024/
LOCATION:Monash Medical Centre\, 246 Clayton Rd\, Clayton\, Victoria\, 3168\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2024/06/Untitled-design.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240729
DTEND;VALUE=DATE:20240730
DTSTAMP:20240611T065727Z
CREATED:20240509T014348Z
LAST-MODIFIED:20240611T065727Z
UID:3363-1722211200-1722297599@www.biocurate.com
SUMMARY:Bio Connections Australia
DESCRIPTION:The 7th Annual Bio Connections Australia will return to Melbourne in 29th July 2024 in the Crown Promenade Melbourne. \nBio Connections Australia is an annual event for the biotech industry which provides a unique platform for networking\, discussion and thought leadership. The conference focuses on translating medical research into commercialisation\, drug discovery and development\, early phase clinical trials and expediting Australia’s great science into commercialisation. \nBringing together key industry stakeholders from across the ecosystem: biotech’s (both domestic and international)\, pharma\, med tech’s\, VC’s\, and other investors\, regulators\, government\, MRI’s\, CRO’s\, trial sites\, universities and clinical trial networks. This 1 day event is a highlight on the ecosystems calendar ensuring ample Q&A\, networking and talks from industry leaders. \n\nDr Kathy Nielsen\, CEO\, is a Chair of the First Session and will be moderating the panel “Investing for Impact”\n\nMore information and registration details can be found here.
URL:https://www.biocurate.com/event/bio-connections-australia/
LOCATION:Crown Promenade Melbourne\, Power Street Reserve 8 Whiteman St\, Southbank\, Melbourne\, Victoria\, 3006\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2024/05/Untitled-design-1-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20240724T110000
DTEND;TZID=Australia/Melbourne:20240724T120000
DTSTAMP:20240703T020548Z
CREATED:20240703T020519Z
LAST-MODIFIED:20240703T020548Z
UID:3408-1721818800-1721822400@www.biocurate.com
SUMMARY:Proof-of-Concept Funding and Development of Therapeutics with BioCurate Information Session at Melbourne Connect
DESCRIPTION:Find out how BioCurate can help you translate your research at our Information Session\nJoin us to learn more about BioCurate’s evaluation and selection process\, the Proof-of-Concept Fund\, and our new funding model\, ahead of the next round of BioCurate Opportunity Assessment (BOA) applications. \nThe information session will be followed by a panel\, and then networking lunch (12pm onwards) at Melbourne Connect. Please let us know if you have any dietary requirements by emailing info@biocurate.com. \nSpeakers: \n \nLocation: \nThe Studio (Ground Floor)\, Melbourne Connect 700 Swanston Street Carlton\, VIC 3053 \n\nClick here to download a map of the venue\nClick here for more information on how to get to Melbourne Connect (including parking details)\n\n  \nRegister via Eventbrite\n 
URL:https://www.biocurate.com/event/proof-of-concept-funding-and-development-of-therapeutics-with-biocurate-information-session-at-melbourne-connect-2024/
LOCATION:The Studio\, Melbourne Connect\, 700 Swanston Street\, Carlton\, Victoria\, 3053\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2023/07/Proof-of-Concept-POC-Funding-and-Development-of-Therapeutics-with-BioCurate.png
ORGANIZER;CN="BioCurate":MAILTO:info@biocurate.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20240716T143000
DTEND;TZID=Australia/Melbourne:20240716T160000
DTSTAMP:20240703T235548Z
CREATED:20240703T233613Z
LAST-MODIFIED:20240703T235548Z
UID:3413-1721140200-1721145600@www.biocurate.com
SUMMARY:Proof-of-Concept Funding and Development of Therapeutics with BioCurate Information Session at Monash University Clayton
DESCRIPTION:Calling all translational researchers!\nThe BioCurate Proof of Concept team will be at the Clayton campus on Tuesday 16 July to present information on this year’s BioCurate Opportunity Assessment round and to hear brief project pitches from researchers that are considering applying to BioCurate for Proof of Concept funding. \nThe BioCurate Proof of Concept scheme allows for funding of up to $500\,000 for a defined set of experiments that will provide industry-standard validation of your discovery. \nRegister the event by email: mnhs.business.development@monash.edu \nIf you are interested in presenting your research to BioCurate on the 16th\, please contact BD team or Monash Innovation: Jack Clemens jack.clemens@monash.edu or Emma Xu emma.xu@monash.edu \nSpeakers: \n \nVenue: Room G19\, 15 Innovation Walk\, Clayton \nTime: Tuesday 16 July 2:30 pm – 4 pm \nThe presentation will be followed by Q&A and project ‘clinic’ hours \n  \n  \n 
URL:https://www.biocurate.com/event/proof-of-concept-funding-and-development-of-therapeutics-with-biocurate-information-session-at-monash-university-clayton-2024/
LOCATION:Room G19\, 15 Innovation Walk\, Monash University\, Room G19\, 15 Innovation Walk\, Clayton\, Victoria\, 3168\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2023/07/Proof-of-Concept-POC-Funding-and-Development-of-Therapeutics-with-BioCurate.png
ORGANIZER;CN="BioCurate":MAILTO:info@biocurate.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20240625T080000
DTEND;TZID=Australia/Melbourne:20240627T170000
DTSTAMP:20240611T010528Z
CREATED:20240419T040704Z
LAST-MODIFIED:20240611T010528Z
UID:3355-1719302400-1719507600@www.biocurate.com
SUMMARY:The 5th Fragment-Based Drug Discovery Down Under Meeting (FBDD-DU5)
DESCRIPTION:The 5th Fragment-Based Drug Discovery Down Under Meeting (FBDD-DU5) will be held at UQ City Campus in Brisbane\, Australia from 25 to 27 June 2024. \nThe 2024 conference will bring together an expanding multidisciplinary group of biologists\, biochemists\, biophysicists\, and chemists from academia and industry to hear about the latest techniques and progress in the dynamic and exciting field of fragment-based drug design. \n\nDr Tifelle Reisinger (Associate Director\, Medicinal Chemistry Discovery and Stakeholder Management) and Dr Julia Beveridge (Scientist\, Small Molecule Therapeutics) will be attending the event\nBioCurate is a sponsor of the event\n\nMore information and registration details can be found here.
URL:https://www.biocurate.com/event/the-5th-fragment-based-drug-discovery-down-under-meeting-fbdd-du5/
LOCATION:UQ City Campus\, 308 Queen St\, Brisbane\, Queensland\, 4000\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2024/04/Untitled-design.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240603T080000
DTEND;TZID=America/Los_Angeles:20240606T170000
DTSTAMP:20240509T051353Z
CREATED:20240509T051353Z
LAST-MODIFIED:20240509T051353Z
UID:3372-1717401600-1717693200@www.biocurate.com
SUMMARY:BIO 2024
DESCRIPTION:The BIO International Convention is the largest and most comprehensive event for biotechnology\, representing the full ecosystem of biotech with over 20\,000 industry leaders from across the globe. \n\nDr Christopher Chan (Executive Director\, Research and Development)\, Dr Eric Hayes (Director of Partnerships) and Francis Kirby (Partnerships and Strategy Manager) will be attending the event\n\nMore information and registration details can be found here.
URL:https://www.biocurate.com/event/bio-2024/
LOCATION:San Diego Convention Center\, 111 Harbor Drive\, San Diego\, CA\, 92101\, United States
ATTACH;FMTTYPE=image/jpeg:https://www.biocurate.com/wp-content/uploads/2024/05/Untitled-design.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231205
DTEND;VALUE=DATE:20231206
DTSTAMP:20231130T011131Z
CREATED:20231117T035954Z
LAST-MODIFIED:20231130T011131Z
UID:3264-1701734400-1701820799@www.biocurate.com
SUMMARY:Innovation 2 Translation 2023
DESCRIPTION:Melbourne Therapeutics (MTx) and Victorian Comprehensive Cancer Centre (VCCC) Alliance presents the third edition of the INNOVATION 2 TRANSLATION symposium – to be held Tuesday 5th December at the Woodward Conference Centre – University of Melbourne (10th Floor\, Melbourne Law Building\, 185 Pelham St\, Carlton). \nA showcase of the current commercial & translational research occurring across the Melbourne Biomedical Precinct\, highlighting remarkable stories focused on therapeutic discovery & development. This year’s symposium will also host an internal pitch session with prizemoney up for grabs and a panel discussion facilitated by investment professionals to discuss the path to research commercialization. Join us for an exciting day of knowledge exchange and networking opportunities. \n\nBioCurate Director of Project Management Dr Cathy Drinkwater will be a speaker on the Research Commercialization Interactive Panel\nBioCurate Associate Director of Project Management Dr Andy Allen will be a judge at the Pitch Session\n\nMore information and registration details can be found here.
URL:https://www.biocurate.com/event/innovation-2-translation-2023/
LOCATION:Woodward Conference Centre\, Law Building\, 10th floor\, 106/185 Pelham St\, Carlton\, Victoria\, 3054\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2023/11/Untitled-design2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231027
DTEND;VALUE=DATE:20231028
DTSTAMP:20231011T050023Z
CREATED:20231011T050023Z
LAST-MODIFIED:20231011T050023Z
UID:3225-1698364800-1698451199@www.biocurate.com
SUMMARY:Hit ID Symposium 2023
DESCRIPTION:The upcoming Hit ID Symposium will be held on 27 October 2023 at the Woodward Conference Centre\, in Melbourne\, Australia. This event will consist of scientific sessions\, interactive events and networking opportunities focussed on introducing delegates to the topic of hit identification within a small molecule drug discovery setting. \nThis is the first small molecule drug discovery symposium showcasing the hit identification infrastructure available within Melbourne’s Parkville precinct\, with a series of drug development success stories. The event provides a unique opportunity to be involved in a wide-reaching symposium that will focus on hit-finding screening campaigns in drug discovery\, delivered by experts actively working in the field from both within academia and industry. \nThe symposium will introduce researchers and clinicians to the topic of small molecule drug discovery and the support available to engage in such a program\, starting with the identification of a hit. Our program will guide participants through the different stages of small molecule drug discovery: how to do it\, how to fund it and how to protect it. This symposium will attract researchers who have an interest in drug discovery from the fields of biology and chemistry and groups involved in the translational and commercialisation space. \n\nBioCurate Associate Director of Medicinal Chemistry Discovery and Stakeholder Management Dr Tifelle Reisinger will be on the Funding Sources Panel discussion\nBioCurate Associate Director of Small Molecule Therapeutics Dr Belinda Huff will be attending\n\nThe program\, more information and registration details can be found here.
URL:https://www.biocurate.com/event/hit-id-symposium-2023/
LOCATION:Woodward Conference Centre\, Law Building\, 10th floor\, 106/185 Pelham St\, Carlton\, Victoria\, 3054\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2023/10/Untitled-design3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20231011T080000
DTEND;TZID=Australia/Melbourne:20231012T170000
DTSTAMP:20231011T045438Z
CREATED:20231011T045438Z
LAST-MODIFIED:20231011T045438Z
UID:3220-1697011200-1697130000@www.biocurate.com
SUMMARY:2023 KCA Annual Conference
DESCRIPTION:This year’s conference program\, taking place at the QT Hotel\, Surfers Paradise\, will feature leading international and national speakers\, panel sessions\, workshops and discussions exploring the importance of our theme \n‘Innovation to Adoption: Delivering Real Impact’. \nDon’t miss your chance to learn from others\, share your experiences and challenges\, as well as participate in the opportunity to network and collaborate with your peers. \n\nBioCurate Director of Project Management Dr Cathy Drinkwater will be attending\n\nThe program\, more information and registration details can be found here.
URL:https://www.biocurate.com/event/2023-kca-annual-conference/
LOCATION:QT Hotel\, Surfers Paradise\, 7 Staghorn Ave\, Surfers Paradise\, Queensland\, 4217\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2023/10/Untitled-design2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20230810T150000
DTEND;TZID=Australia/Melbourne:20230810T160000
DTSTAMP:20230727T064240Z
CREATED:20230727T064240Z
LAST-MODIFIED:20230727T064240Z
UID:3134-1691679600-1691683200@www.biocurate.com
SUMMARY:Proof-of-Concept Funding and Development of Therapeutics with BioCurate Information Session at Monash University Clayton
DESCRIPTION:Find out how BioCurate can help you translate your research at our Information Session\nJoin us to learn more about BioCurate\, BioCurate’s evaluation process\, selection and funding process\, as well as the Proof-of-Concept Fund\, ahead of the next round of BioCurate Opportunity Assessment (BOA) applications (open 7 August – close 15 September 2023). \nThe information session will be followed by a panel. \nSpeakers: \n \nLocation: \nWoodside Building for Technology and Design\nMeeting Room G01 (Ground floor\, Meeting Room 1)\nMonash University\, 20 Exhibition Walk\, Clayton \n 
URL:https://www.biocurate.com/event/proof-of-concept-funding-and-development-of-therapeutics-with-biocurate-information-session-at-monash-university-clayton/
LOCATION:Woodside Building for Technology and Design\, Meeting Room G01 (Ground floor\, Meeting Room 1)\, Monash University\, 20 Exhibition Walk\, Clayton\, Victoria\, 3168\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2023/07/Proof-of-Concept-POC-Funding-and-Development-of-Therapeutics-with-BioCurate.png
ORGANIZER;CN="BioCurate":MAILTO:info@biocurate.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20230809T110000
DTEND;TZID=Australia/Melbourne:20230809T120000
DTSTAMP:20230727T063743Z
CREATED:20230727T063442Z
LAST-MODIFIED:20230727T063743Z
UID:3126-1691578800-1691582400@www.biocurate.com
SUMMARY:Proof-of-Concept Funding and Development of Therapeutics with BioCurate Information Session at Melbourne Connect
DESCRIPTION:Find out how BioCurate can help you translate your research at our Information Session\nJoin us to learn more about BioCurate\, BioCurate’s evaluation process\, selection and funding process\, as well as the Proof-of-Concept Fund\, ahead of the next round of BioCurate Opportunity Assessment (BOA) applications (open 7 August – close 15 September 2023). \nThe information session will be followed by a panel\, and then networking lunch (12pm onwards) at Melbourne Connect. \nSpeakers: \n \nLocation: \nThe Studio (Ground Floor)\, Melbourne Connect 700 Swanston Street Carlton\, VIC 3053 \n\nClick here to download a map of the venue\nClick here for more information on how to get to Melbourne Connect (including parking details)\n\n  \nRegister via Eventbrite\n 
URL:https://www.biocurate.com/event/proof-of-concept-funding-and-development-of-therapeutics-with-biocurate-information-session-at-melbourne-connect/
LOCATION:The Studio\, Melbourne Connect\, 700 Swanston Street\, Carlton\, Victoria\, 3053\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2023/07/Proof-of-Concept-POC-Funding-and-Development-of-Therapeutics-with-BioCurate.png
ORGANIZER;CN="BioCurate":MAILTO:info@biocurate.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20211118T080000
DTEND;TZID=Australia/Melbourne:20211118T170000
DTSTAMP:20210813T025924Z
CREATED:20210520T023202Z
LAST-MODIFIED:20210813T025924Z
UID:2814-1637222400-1637254800@www.biocurate.com
SUMMARY:BioConnections Australia 2021
DESCRIPTION:Bio Connections Australia explores drug development\, early phase clinical trials\, translational research and expediting Australia’s great science into commercialization. \n2020 saw significant disruption to the drug development and clinical trials landscape in Australia and around the world. Australia’s response was remarkable in its ability to respond to the challenges and capture opportunities. How we maintain that momentum and build upon this is an important theme for discussion in 2021. \nOngoing work is needed to drive Australia to become globally competitive in novel therapeutics and create better pathways for companies to translate their great research into commercial products. From effective early partnering to funding plans for translation and commercialisation – this event is a critical opportunity for dialogue and debate between key stakeholders. \nAustralia is now well known as a leading destination for early phase clinical trials. The next step is to ensure we maintain the efficiencies and innovations adopted during the pandemic and build upon them. What are the innovative models which can be adopted and sustained? What are the opportunities with new tech and devices within clinical trials and what are the regulatory considerations? \n\nBioCurate Chairman and Director the Hon John Brumby will be delivering the opening keynote address\nBioCurate COO Linda Peterson and founding CEO Dr C. Glenn Begley will also be speaking at the meeting\n\nThe program\, more information and registration details can be found here.
URL:https://www.biocurate.com/event/bioconnections-australia-2021/
LOCATION:Rydges Melbourne\, 186 Exhibition St\, Melbourne\, Victoria\, 3000\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2021/05/Untitled-design5.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201116
DTEND;VALUE=DATE:20201117
DTSTAMP:20200921T050405Z
CREATED:20200820T061404Z
LAST-MODIFIED:20200921T050405Z
UID:2604-1605484800-1605571199@www.biocurate.com
SUMMARY:BioConnections Australia
DESCRIPTION:Bio Connections Australia explores drug development\, early phase clinical trials\, translational research and expediting Australia’s great science into commercialization. It comes at a critical time for Australia’s medical research sector. \nThe focus of the agenda this year will be on translation and commercialization of homegrown Australian research\, improving drug development and clinical trials in Australia as well as the impact of COVID-19 on the landscape. \nBio Connections Australia provides an important platform for further discussion and debate on what the challenges\, opportunities and realities may be for drug development\, clinical trials and medical research in Australia. \nBioCurate CEO Dr C. Glenn Begley will be on the Panel Discussion: How Do we Get More Australian Programs into Clinical Trials from Homegrown IP? \nThe program\, more information and registration details can be found here.
URL:https://www.biocurate.com/event/bioconnections-australia/
LOCATION:Virtual event
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2020/08/Bio-Connections-Australia.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20201028T080000
DTEND;TZID=Australia/Melbourne:20201030T170000
DTSTAMP:20200921T050323Z
CREATED:20200921T050323Z
LAST-MODIFIED:20200921T050323Z
UID:2661-1603872000-1604077200@www.biocurate.com
SUMMARY:AusBiotech + Invest 2020
DESCRIPTION:AusBiotech + Invest 2020 – Australia’s largest life science conference is back and will be delivered online live 28 – 30 October and on-demand. \nThe world has changed and AusBiotech + Invest 2020 has moved online to ensure maximum flexibility and accessibility. Australia’s biggest week in biotech will feature the event you’ve known and trusted for 35 years\, with new opportunities for global delegates and speakers\, and a new level of global insight and perspective. \nBioCurate will be exhibiting at AusBiotech + Invest 2020 and supporting the Early Stage Investment Forum with the BioCurate Award for Best Translational Research. Further details will be provided at a later date. \nThe program\, more information and registration details can be found here.
URL:https://www.biocurate.com/event/ausbiotech-invest-2020/
LOCATION:Virtual event
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2020/09/Untitled-design4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20200420T080000
DTEND;TZID=Australia/Melbourne:20200421T170000
DTSTAMP:20200406T050427Z
CREATED:20200217T003423Z
LAST-MODIFIED:20200406T050427Z
UID:2354-1587369600-1587488400@www.biocurate.com
SUMMARY:Business of Regenerative Medicine Asia Pacific
DESCRIPTION:In light of the COVID-19 policy statements by the Commonwealth\, Victorian and New South Wales Governments\, and in order to provide certainty to the presenters\, registrants and sponsors\, the inaugural Business of Regenerative Medicine Asia Pacific Symposium has been cancelled. \nCCRM Australia and the New South Wales Stem Cell Network are co-hosting the Business of Regenerative Medicine Asia Pacific symposium from 20th to 21st April 2020 in Sydney Australia. \nThe Symposium will be hosted at the offices of our venue sponsor\, legal firm King & Woods Mallesons\, with spectacular views of the Sydney Harbour\, and a third optional day will be offered to visiting delegates to tour NSW’s cutting edge facilities. \nModelled on the successful Business of Regenerative Medicine Meetings held in North America\, our symposium will unite the field’s leading organizations\, industry players\, business talent and investigative minds to share their considerable knowledge and “in the trenches” experience. \nBioCurate CEO Dr C. Glenn Begley will be presenting at the meeting. \nThe full program is available from CCRM Australia & the NSW Stem Cell Network’s website. For more information\, contact the Symposium organisers at email: brmapac@gmail.com \nClick here for more information and to register
URL:https://www.biocurate.com/event/business-of-regenerative-medicine-asia-pacific/
LOCATION:King & Wood Mallesons\, Level 61 Governor Phillip Tower\, 1 Farrer Place\, Sydney\, NSW\, 2000\, Australia
ATTACH;FMTTYPE=image/jpeg:https://www.biocurate.com/wp-content/uploads/2020/02/thumbnail_CCRM_Australia_Workshop_BANNER.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20200325T080000
DTEND;TZID=Australia/Melbourne:20200327T170000
DTSTAMP:20200322T224502Z
CREATED:20200305T022839Z
LAST-MODIFIED:20200322T224502Z
UID:2413-1585123200-1585328400@www.biocurate.com
SUMMARY:Eradicate Cancer 2020 – Next frontiers in immunotherapy
DESCRIPTION:Due to the evolving global medical crisis caused by the COVID-19 pandemic and its current escalation in Australia\, the Eradicate Cancer organisers have decided to postpone the conference. \nThe conference is currently awaiting clarification on the situation before going any further. Plenty of notification will be given about new dates once settled. \nThis conference brings together the necessary ingredients to create a meaningful immunotherapeutic platform to attack cancer and step down the path to potentially cure it. The 2020 Eradicate Cancer conference will be held at the Melbourne Convention and Exhibition Centre. \nBioCurate Board Chairman the Honourable John Brumby will be introducing the session “THE SUMMIT” – If money was no object\, how can we eradicate cancer – is Immunotherapy the answer? on Friday\, 27th March. \nClick here for more information and to register
URL:https://www.biocurate.com/event/eradicate-cancer-2020-next-frontiers-in-immunotherapy/
LOCATION:Melbourne Convention and Exhibition Centre\, 1 Convention Centre Place\, Melbourne\, Victoria\, 3006\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2020/03/EC_2020_cmyk_logo_transparent-1200x533-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20200221T120000
DTEND;TZID=Australia/Melbourne:20200221T130000
DTSTAMP:20200217T014348Z
CREATED:20200217T014348Z
LAST-MODIFIED:20200217T014348Z
UID:2358-1582286400-1582290000@www.biocurate.com
SUMMARY:Westmead Biomedical Translation Bridge Program Information Session: Round 2
DESCRIPTION:The Biomedical Translation Bridge (BTB) Program is an initiative of the Medical Research Future Fund\, providing up to $1 million in matching funding to nurture the translation of new therapies\, technologies and medical devices through to the proof of concept stage. \nThe BTB program is operated by MTPConnect in partnership with BioCurate\, UniQuest\, the Medical Device Partnering Program and the Bridge and BridgeTech programs. \nBioCurate Director of Partnerships Dr Eric Hayes will be in attendance. Please join us and our partners at the Westmead Institute of Medical Research to find out more about the BTB Program. \nClick here for more information and to register.
URL:https://www.biocurate.com/event/westmead-biomedical-translation-bridge-program-information-session-round-2/
LOCATION:Westmead Institute of Medical Research\, 176 Hawkesbury Road\, Westmead\, NSW\, 2145\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2019/10/Untitled-design-2019-12-12T125614.053.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20200219T080000
DTEND;TZID=Australia/Melbourne:20200221T170000
DTSTAMP:20200110T010417Z
CREATED:20200110T010417Z
LAST-MODIFIED:20200110T010417Z
UID:2304-1582099200-1582304400@www.biocurate.com
SUMMARY:Lorne Infection and Immunity Conference 2020
DESCRIPTION:The Lorne Infection and Immunity Conference brings together scientists\, students\, health care and industry from multiple disciplines with a shared interest in infection and immunity research. \nBioCurate CEO Dr C. Glenn Begley will be presenting Thursday 20 February as part of the Infection and immunity in translation afternoon session. \nFor more information\, visit the Lorne Infection and Immunity Conference 2020 website.
URL:https://www.biocurate.com/event/lorne-infection-and-immunity-conference-2020/
LOCATION:Cumberland Lorne Resort\, 150 Mountjoy Parade\, Lorne\, Victoria\, Australia
ATTACH;FMTTYPE=image/jpeg:https://www.biocurate.com/wp-content/uploads/2020/01/II2020Webbanner1-e1578618121604.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20200212T103000
DTEND;TZID=Australia/Melbourne:20200212T123000
DTSTAMP:20200113T033141Z
CREATED:20200113T033037Z
LAST-MODIFIED:20200113T033141Z
UID:2329-1581503400-1581510600@www.biocurate.com
SUMMARY:Brisbane Biomedical Translation Bridge Program Information Session: Round 2
DESCRIPTION:The Biomedical Translation Bridge (BTB) Program is an initiative of the Medical Research Future Fund\, providing up to $1 million in matching funding to nurture the translation of new therapies\, technologies and medical devices through to the proof of concept stage. \nThe BTB program is operated by MTPConnect in partnership with BioCurate\, UniQuest\, the Medical Device Partnering Program and the Bridge and BridgeTech programs. \nBioCurate Director of Partnerships Dr Eric Hayes will be in attendance. Please join us and our partners at the Translational Research Institute to find out more about the BTB Program. \nClick here for more information and to register.
URL:https://www.biocurate.com/event/brisbane-biomedical-translation-bridge-program-information-session-round-2/
LOCATION:Translational Research Institute\, 37 Kent Street\, Woolloongabba\, Brisbane\, QLD\, 4102\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2019/10/Untitled-design-2019-12-12T125614.053.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20200205T100000
DTEND;TZID=UTC:20200205T120000
DTSTAMP:20200113T033137Z
CREATED:20200113T032447Z
LAST-MODIFIED:20200113T033137Z
UID:2326-1580896800-1580904000@www.biocurate.com
SUMMARY:Adelaide Biomedical Translation Bridge Program Information Session: Round 2
DESCRIPTION:The Biomedical Translation Bridge (BTB) Program is an initiative of the Medical Research Future Fund\, providing up to $1 million in matching funding to nurture the translation of new therapies\, technologies and medical devices through to the proof of concept stage. \nThe BTB program is operated by MTPConnect in partnership with BioCurate\, UniQuest\, the Medical Device Partnering Program and the Bridge and BridgeTech programs. \nBioCurate Director of Partnerships Dr Eric Hayes will be in attendance. Please join us and our partners at the Royal Institution of Australia to find out more about the BTB Program. \nClick here for more information and to register.
URL:https://www.biocurate.com/event/adelaide-biomedical-translation-bridge-program-information-session-round-2/
LOCATION:The Royal Institution of Australia\, 55 Exchange Place\, Adelaide\, SA\, 5000\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2019/10/Untitled-design-2019-12-12T125614.053.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20200203T140000
DTEND;TZID=Australia/Melbourne:20200203T160000
DTSTAMP:20200113T033128Z
CREATED:20191212T025547Z
LAST-MODIFIED:20200113T033128Z
UID:2162-1580738400-1580745600@www.biocurate.com
SUMMARY:Sydney Biomedical Translation Bridge Program Information Session: Round 2
DESCRIPTION:The Biomedical Translation Bridge (BTB) Program is an initiative of the Medical Research Future Fund\, providing up to $1 million in matching funding to nurture the translation of new therapies\, technologies and medical devices through to the proof of concept stage. \nThe BTB program is operated by MTPConnect in partnership with BioCurate\, UniQuest\, the Medical Device Partnering Program and the Bridge and BridgeTech programs. \nBioCurate Director of Partnerships Dr Eric Hayes will be in attendance. Please join us and our partners at the University of Sydney to find out more about the BTB Program. \nClick here for more information and to register.
URL:https://www.biocurate.com/event/btb-r2/
LOCATION:The University of Sydney\, Camperdown\, Sydney\, NSW\, 2006\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2019/10/Untitled-design-2019-12-12T125614.053.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Shanghai:20191203T160000
DTEND;TZID=Asia/Shanghai:20191203T180000
DTSTAMP:20191212T025708Z
CREATED:20191029T033548Z
LAST-MODIFIED:20191212T025708Z
UID:372-1575388800-1575396000@www.biocurate.com
SUMMARY:Biomedical Translation Bridge Program Information Session: Perth
DESCRIPTION:The Biomedical Translation Bridge (BTB) Program is an initiative of the Medical Research Future Fund\, providing up to $1 million in matching funding to nurture the translation of new therapies\, technologies and medical devices through to the proof of concept stage. \nThe BTB program is operated by MTPConnect in partnership with BioCurate\, UniQuest\, the Medical Device Partnering Program and the Bridge and BridgeTech programs. \nPlease join us and our partners at the Harry Perkins Institute of Medical Research to find out more about the next round of the BTB Program. BioCurate Director of Partnerships Dr Erid Hayes will be on the panel. \nClick here for more information and to register.
URL:https://www.biocurate.com/event/btb-perth/
LOCATION:Harry Perkins Institute of Medical Research\, 6 Verdun Street\, Perth\, Western Australia\, 6009\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2019/10/Untitled-design-2019-12-12T125614.053.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20191127T100000
DTEND;TZID=Australia/Melbourne:20191129T170000
DTSTAMP:20191212T024112Z
CREATED:20191029T033457Z
LAST-MODIFIED:20191212T024112Z
UID:369-1574848800-1575046800@www.biocurate.com
SUMMARY:The 6th Annual EMBL Australia Postgraduate Symposium
DESCRIPTION:This year’s EMBL Australia Postgraduate Symposium (EAPS19) in Melbourne with the theme “From Models to Systems” which focuses on looking at biology from multiple perspectives to better understand it as a whole\, from micro-organisms to large ecosystems. EMBL Australia welcomes and encourages all Honours\, Masters & PhD Students to attend EAPS19; the symposium is an excellent opportunity for students to learn from world leading researchers\, as well as network with a range of other like-minded students and present their work in a friendly and professional environment. \nBioCurate Chief Scientific Officer and Head of Translational Medicine will be delivering the Plenary Address\, Translating Science\, while Program Manager will be at the BioCurate trade display on Friday 29 November. \nClick here for more information and to register.
URL:https://www.biocurate.com/event/eaps2019/
LOCATION:Victorian Comprehensive Cancer Centre\, 305 Grattan St\, Melbourne\, Victoria\, 3000\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2019/10/Untitled-design-2019-12-12T133411.485.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20191121T083000
DTEND;TZID=Australia/Melbourne:20191121T170000
DTSTAMP:20191212T025107Z
CREATED:20191028T162227Z
LAST-MODIFIED:20191212T025107Z
UID:365-1574325000-1574355600@www.biocurate.com
SUMMARY:Innovation to Translation symposium
DESCRIPTION:Melbourne Therapeutics Development presents the inaugural INNOVATION TO TRANSLATION symposium. \nA showcase of the Melbourne Biomedical Precinct’s remarkable achievements in therapeutics development. Discover the facilities and expertise available to help you translate your research into new therapies and meet with industry and academic leaders. \nBioCurate will be sponsoring the ‘Funding Opportunities’ session\, during which Director of Small Molecule Therapeutics Dr Lorna Mitchelle will be speaking. \nClick here for more information and to register.
URL:https://www.biocurate.com/event/innovation-to-translation19/
LOCATION:Walter and Eliza Hall Institute\, 1G Royal Parade\, Melbourne\, Victoria\, 3052\, Australia
ATTACH;FMTTYPE=image/png:https://www.biocurate.com/wp-content/uploads/2019/10/Untitled-design-2019-12-12T134941.503.png
END:VEVENT
END:VCALENDAR